Drugs / OxigenOzone
Trials 2
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1/2 | NCT06072404 | Feb 2018 → Mar 2020 | osteonecrosis of the jaw | University of Palermo | Completed | No outcome recorded |
| Phase 1/2 | NCT05036837 | Feb 2018 → Mar 2020 | osteonecrosis of the jaw | University of Palermo | Suspended | No outcome recorded |
Evidence & citations 4 cited values
Every value below carries the sentence it was read from. 2 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | OxigenOzone | “intra-tissue injection of a 15 ml OxigenOzone (O2O3) mixture by 26Gx 1⁄2 - 0.45x13mm needle into the mucosal margin surrounding the bone exposure or around the situs already...” NCT05036837 ↗ |
| Known as | O2O3 | “intra-tissutal perialveolar injections of a 15-mL mixture of OxigenOzone (O2O3) with a 26Gx 1⁄2 - 0.45x13 mm needle and insufflation of the same mixture in the post-extraction...” NCT06072404 ↗ |
| Modality | Other / unclassified | “the use of medical ozone (O3)” NCT05036837 ↗ |
| Route | Other | “intra-tissue injection of a 15 ml OxigenOzone (O2O3) mixture” NCT05036837 ↗ |